STMicroelectronics NV (NYSE:STM)
STMicroelectronics NV (NYSE:STM) added 1.39% and closed its last session at $10.94. The stock has the market capitalization of $9.95 Billion with the total outstanding shares of 909.05 Million. STMicroelectronics NV. has Analysts’ Mean Recommendation of 2 between the scale of 1 to 5 (1 represents Strong Buy and 5 means Sell). The stock currently has P/E of 176.45 for trailing twelve months while its Forward P/E is 20.49.
STMicroelectronics NV (NYSE:STM) touched its 52-Week High of $11 on Dec 19, 2016 while it’s 52-Week Low of $5.11 on Apr 6, 2016. The company currently has Return on Assets of 0.7 percent, Return on Equity of 1.2% and Return on Investment of 2.1 percent. The stock currently showing Weekly Volatility of 1.43%% and Monthly Volatility of 1.82% Percent with Average True Range of 0.24 and Beta of 0.91.
The 24 analysts offering 12-month price forecasts for STMicroelectronics NV have a median target of 8.92, with a high estimate of 12.60 and a low estimate of 5.37. The median estimate represents a -18.45% decrease from the last price of 10.94.
Press Release:
The Electronic Components and Systems for European Leadership (ECSEL) Joint Undertaking on 28 November declared the Lab4MEMS project as the winner of its 2016 Innovation Award during the European Nanoelectronics Forum, in Rome, Italy.
At its launch in January 2014, Lab4MEMS was identified as a Key Enabling Technology Pilot-Line project for next-generation Micro-Electro-Mechanical Systems (MEMS) devices augmented with advanced technologies such as piezoelectric or magnetic materials and 3D packaging to enhance the next generation of smart sensors, actuators, micro-pumps, and energy harvesters. These technologies were recognized as important contributors to future data-storage, printing, healthcare, automotive, industrial-control, and smart-building applications, as well as consumer applications such as smartphones and navigation devices.
In coordinating the €28m[1], 36-month Lab4MEMS project, ST led the team of twenty partners, which included universities, research institutions, and technology businesses across ten European countries. ST’s MEMS facilities in Italy and Malta contributed their complete set of manufacturing competencies for next-generation devices, spanning design and fabrication to test and packaging to the project.
Company Profile:
STMicroelectronics is a global independent semiconductor company which designs, develops, manufactures and markets a broad range of semiconductor integrated circuits and discrete devices used in a wide variety of microelectronic applications, including telecommunications systems, computer systems, consumer products, automotive products and industrial automation and control systems.
Walgreens Boots Alliance, Inc. (NASDAQ:WBA)
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) retreated -0.02% and closed its last session at $86.06. The stock has the market capitalization of $92.48 Billion with the total outstanding shares of 1.07 Billion. Walgreens Boots Alliance, Inc.. has Analysts’ Mean Recommendation of 1.59 between the scale of 1 to 5 (1 represents Strong Buy and 5 means Sell). The stock currently has P/E of 22.51 for trailing twelve months while its Forward P/E is 15.57.
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) touched its 52-Week High of $88 on Dec 14, 2016 while it’s 52-Week Low of $71.5 on Feb 8, 2016. The company currently has Return on Assets of 6.1 percent, Return on Equity of 13.8% and Return on Investment of 10.2 percent. The stock currently showing Weekly Volatility of 1.79%% and Monthly Volatility of 1.51% Percent with Average True Range of 1.42 and Beta of 1.18.
The 21 analysts offering 12-month price forecasts for Walgreen have a median target of 95.00, with a high estimate of 100.00 and a low estimate of 70.00. The median estimate represents a +10.39% increase from the last price of 86.06.
Latest News:
The Company on 15 December launched its first Flu Index™ for the 2016-17 season, a weekly report that ranks the top markets and states for flu activity in the U.S. This year’s Flu Index will include Puerto Rico for the first time.
Now in its third year, the Walgreens Flu Index is compiled using the drugstore chain’s weekly retail prescription data for antiviral medications used to treat influenza across Walgreens locations nationwide and in Puerto Rico. In addition to the top markets and states for activity, the Flu Index also ranks those experiencing the greatest gains on a week-over-week basis.
“While flu activity remains relatively low across most of the U.S., our data suggests a gradual increase in incidences of flu in a growing number of markets,” said Richard Ashworth, Walgreens president of pharmacy and retail operations. “Even with a slower start to flu season, the Flu Index helps health officials, media and consumers stay informed about the flu in their local community.”
Company Profile:
Walgreens Boots Alliance, Inc. operates as a retail drugstore chain. The Company sells prescription and non-prescription drugs, as well as general merchandise products, including household items, convenience and fresh foods, personal care, beauty care, photofinishing and candy. Its pharmacy, health and wellness services include retail, specialty, infusion and respiratory services, mail service and convenient care clinics. The Company offers its products and services through drugstores, as well as through mail, by telephone and online. Walgreens Boots Alliance, Inc., is based in Deerfield, Illinois.